Management Change21 Apr 2026, 05:01 pm
Indo Us Bio-Tech appoints Hemanshi Soni as Independent Director
AI Summary
Indo Us Bio-Tech Ltd. has announced the appointment of Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director, serving as a Non-Executive Independent Director. The Board of Directors approved her appointment on April 21, 2026, for a five-year term, effective from the same date. This appointment is contingent upon the approval of shareholders at the upcoming Annual General Meeting. The company confirmed that Mrs. Soni has no relation to any existing Directors or Key Managerial Personnel, ensuring her independence. The appointment adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.
Key Highlights
- Board appointed Mrs. Hemanshi Soni as Additional Independent Director.
- Her tenure is for five years, effective April 21, 2026.
- Appointment requires shareholder approval at the next AGM.
- She is unrelated to existing directors, ensuring independence.
Price Impact
More from INDOUS